The following analysts provide research coverage of Human Genome Sciences, Inc. (NASDAQ: HGSI).

Bear Stearns
Mark J. Schoenebaum, M.D.

BernsteinResearch
Geoffrey C. Porges, MBBS

Citigroup Investment Research
Yaron Werber, MD

Goldman Sachs
Meg Malloy

JMP Securities
Charles C. Duncan, Ph.D.

JPMorgan
Richard E. Smith, Ph.D. 

Lazard Capital Markets
Terence C. Flynn, Ph.D.

Leerink Swann
Joseph P. Schwartz

Lehman Brothers
Jim Birchenough, M.D.

Morgan Stanley
Sapna Srivastava, Ph.D. 

Piper Jaffray
Edward A. Tenthoff

R.W. Baird
Christopher J. Raymond

Stanford Financial Group
Hanzhong Li, Ph.D.

Susquehanna Financial Group
Jason Kolbert

Thomas Wiesel Partners
M. Ian Somaiya

UBS
Annabel Samimy

Wachovia Securities
George Farmer, Ph.D.

Human Genome Sciences, Inc. ("HGS") makes no representation as to the accuracy or completeness of any of these analysts' reports. The projections and analysis therein are those of the authors of the reports, and are not endorsed by or on behalf of HGS and HGS does not undertake to update or correct any information contained therein. Factual information and opinions expressed in the reports are the responsibility of the author of the report and are subject to change.